{"disease":{"id":"dysmorphic-features","name":"dysmorphic features"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03548779","title":"North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2","phase":"NA","overall_status":"COMPLETED","enrollment_count":548,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT05258409","title":"Evaluating Body Acceptance Programs for Young Men","phase":"NA","overall_status":"COMPLETED","enrollment_count":241,"lead_sponsor_name":"Auburn University","has_results":false},{"nct_id":"NCT04709965","title":"Evaluating Face-Recognition Technology in Syndrome Diagnosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT04382573","title":"Better Delineation of CDK13 Related Phenotype and Epigenetic Signature.","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}